These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
72 related articles for article (PubMed ID: 14983243)
1. Severe intra-abdominal bleeding post liver biopsy - failure to respond to recombinant Factor VII. Quinn JP; Murphy PT Thromb Haemost; 2004 Mar; 91(3):632-3. PubMed ID: 14983243 [No Abstract] [Full Text] [Related]
2. Successful use of recombinant activated factor VII (Novoseven) in controlling severe intra-abdominal bleeding after liver needle biopsy. Hoffman R; Mahajana A; Agmon P; Baruch Y; Brenner B Thromb Haemost; 2002 Feb; 87(2):346-7. PubMed ID: 11858500 [No Abstract] [Full Text] [Related]
3. Recombinant activated factor VII (NovoSeven) stops severe intra-abdominal bleeding after liver needle biopsy without surgery. Sendensky A; Gutzwiller JP; Schneider-Frost J; Wuillemin WA; Graeni R; Beglinger C Blood Coagul Fibrinolysis; 2004 Oct; 15(8):701-2. PubMed ID: 15613927 [No Abstract] [Full Text] [Related]
4. Administration of recombinant activated factor VII (NovoSeven) in three cases of uncontrolled bleeding caused by disseminated intravascular coagulopathy. Schmid S; Friesenecker B; Lorenz I; Innerhofer P; Koscielny J; Velik-Salchner C; Mutz N; Fries D Clin Appl Thromb Hemost; 2007 Jul; 13(3):313-7. PubMed ID: 17636194 [TBL] [Abstract][Full Text] [Related]
5. Treatment of intra-abdominal bleeding with recombinant activated factor VII in a patient with disseminated intravascular coagulation secondary to septic shock. Martínez J; Cid AR; de la Rubia J; Gimeno R Blood Coagul Fibrinolysis; 2005 Jun; 16(4):297-9. PubMed ID: 15870551 [TBL] [Abstract][Full Text] [Related]
6. A clinical review of bleeding dilemmas in trauma. Hoyt DB Semin Hematol; 2004 Jan; 41(1 Suppl 1):40-3. PubMed ID: 14872420 [TBL] [Abstract][Full Text] [Related]
7. Potential role of recombinant activated factor VII for the treatment of severe bleeding associated with disseminated intravascular coagulation: a systematic review. Franchini M; Manzato F; Salvagno GL; Lippi G Blood Coagul Fibrinolysis; 2007 Oct; 18(7):589-93. PubMed ID: 17890943 [TBL] [Abstract][Full Text] [Related]
8. Recombinant factor VIIa after amniotic fluid embolism and disseminated intravascular coagulopathy. Lim Y; Loo CC; Chia V; Fun W Int J Gynaecol Obstet; 2004 Nov; 87(2):178-9. PubMed ID: 15491576 [TBL] [Abstract][Full Text] [Related]
9. Experiences with recombinant factor VIIa for the prevention of bleeding in patients with chronic liver disease undergoing percutaneous liver biopsies and endoscopic retrograde cholangiopancreatography (ERCP). Kositchaiwat C; Chuansumrit A Thromb Haemost; 2001 Oct; 86(4):1125-6. PubMed ID: 11686340 [No Abstract] [Full Text] [Related]
10. Use of recombinant factor VII to control bleeding in a patient supported by right ventricular assist device after heart transplantation. Kogan A; Berman M; Kassif Y; Raanani E; Stamler A; Ben Gal T; Stein M; Erez E; Vidne BA; Sahar G J Heart Lung Transplant; 2005 Mar; 24(3):347-9. PubMed ID: 15737765 [TBL] [Abstract][Full Text] [Related]
11. [Factor VII, a therapeutic alternative in the treatment of severe haemoghage disorders]. Morales León V; Herrera Ortega G; Molero Gómez R; García Cortés J Farm Hosp; 2003; 27(1):38-41. PubMed ID: 12607015 [TBL] [Abstract][Full Text] [Related]
12. [Recombinant activated factor VII used in a man with refractory bleeding from a stab wound injuring the liver and kidney]. Arnal D; Piñeiro P; Garutti I; Olmedilla L; Sanz J; Lajara A Rev Esp Anestesiol Reanim; 2004 May; 51(5):284-8. PubMed ID: 15214766 [TBL] [Abstract][Full Text] [Related]
13. Single-center experience: use of recombinant factor VIIa for acute life-threatening bleeding in children without congenital hemorrhagic disorder. Yilmaz D; Karapinar B; Balkan C; Akisü M; Kavakli K Pediatr Hematol Oncol; 2008 Jun; 25(4):301-11. PubMed ID: 18484474 [TBL] [Abstract][Full Text] [Related]
14. Effective treatment of severe bleeding due to acquired thrombocytopathia by single dose administration of activated recombinant factor VII. Meijer K; Sieders E; Slooff MJ; de Wolf JT; van der Meer J Thromb Haemost; 1998 Jul; 80(1):204-5. PubMed ID: 9684815 [No Abstract] [Full Text] [Related]
15. Intraoperative pediatric blood transfusion therapy: a review of common issues. Part II: transfusion therapy, special considerations, and reduction of allogenic blood transfusions. Barcelona SL; Thompson AA; Coté CJ Paediatr Anaesth; 2005 Oct; 15(10):814-30. PubMed ID: 16176309 [No Abstract] [Full Text] [Related]
16. Successful treatment of massive acute upper gastrointestinal bleeding in liver failure with activated recombinant factor VII (NovoSeven): a case report. Tonkic A; Jukic I; Titlic M; Mise S Blood Coagul Fibrinolysis; 2005 Jul; 16(5):385-7. PubMed ID: 15970725 [No Abstract] [Full Text] [Related]
17. Successful outcome of using recombinant activated factor VII (rFVIIa) in liver biopsy in a patient with liver failure. Al Sobhi E J Thromb Haemost; 2006 Sep; 4(9):2073-4. PubMed ID: 16961618 [No Abstract] [Full Text] [Related]
18. Life-threatening hemorrhage in neonates: management with recombinant activated factor VII. Veldman A; Fischer D; Voigt B; Beyer PA; Schlösser R; Allendorf A; Kreuz W Intensive Care Med; 2002 Nov; 28(11):1635-7. PubMed ID: 12415453 [TBL] [Abstract][Full Text] [Related]
19. [Place of recombinant activated factor VII in the treatment of severe haemorrhage in paediatric patients]. Veyckemans F Ann Fr Anesth Reanim; 2009; 28(7-8):676-7. PubMed ID: 19574019 [No Abstract] [Full Text] [Related]
20. "Evaluation of off-label recombinant activated factor VII for multiple indications in children" by Reiter et al. de Miranda PA Clin Appl Thromb Hemost; 2008 Apr; 14(2):247; author reply 247. PubMed ID: 18372280 [No Abstract] [Full Text] [Related] [Next] [New Search]